Perbedaan Organon Pharma Indonesia Tbk. dan Chandra Asri Pacific Tbk.: Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M), sedangkan Chandra Asri Pacific Tbk. diperdagangkan di Rp1.880 (kapitalisasi pasar 166,97 T, volume 24 jam 197,42 jt). Perbedaan utamanya: Chandra Asri Pacific Tbk. jauh lebih besar — sekitar 1599,3× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| SCPI | TPIA | |
|---|---|---|
Kapitalisasi Pasar | 104,4 M | 166,97 T |
Volume | — | 197,42 jt |
Lot | — | 1,97 jt |
Perputaran | — | 373,29 M |
Harga Rata-rata | — | 1.890,87 |
Nilai Transaksi | — | 373,29 M |
Harga Ekuilibrium Indikatif | — | 1.880 |
Volume Ekuilibrium Indikatif | — | 33,45 rb |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →PT Chandra Asri Petrochemical Tbk formerly PT. Tri Polyta Indonesia, Tbk (the Company) was established under the Domestic Capital Investment Law No. 6 year 1968 and Law No. 12 year 1970 by Notarial Deed No. 40 dated November 2, 1984 of Ridwan Suselo, S.H., notary public in Jakarta. The Company is the largest Indonesia producer of polypropyleneresins that are used in the manufacture of a wide range of consumer products.
Selengkapnya di halaman TPIA →